AR and Patent ductus arteriosus: Primary ductal adenocarcinoma (PDA) was ruled out as Androgen receptor (AR) and GCDFP-15 were negative in the present tumour cells favouring a diagnosis of adenocarcinoma NOS than PDA in which 90–95 % cases are reported to be positive for these markers.3